BRIEF-Ovascience says commenced public offering of common stock
May 25, 2016 at 17:20 PM EDT
* To use proceeds to fund commercial expansion of augment treatment in key regions, ongoing pre-commercial activities for Ovaprime
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.